|
|
||||||||
1 Department of Pediatrics and the Cardiovascular Center, University of Iowa, Iowa City, Iowa 52242; and 2 School of Physiology and Pharmacology, University of New South Wales, Sydney, Australia 2052
| |
ABSTRACT |
|---|
|
|
|---|
Renal sympathetic nerve activity (RSNA) increases rapidly after delivery of term fetal sheep and parallels the rise in heart rate (HR) and arterial pressure. To examine the RSNA response at birth in immature lambs, experiments were performed in chronically instrumented preterm fetal sheep (118- to 125-day gestation, term 145 days) before and after delivery by cesarean section. HR remained unchanged from fetal values at 1 and 4 h after birth, whereas mean arterial blood pressure (MABP) decreased significantly (P < 0.05) by 4 h after delivery. RSNA significantly decreased after premature birth in all animals studied (n = 6), achieving only 39 ± 17% of fetal RSNA (P < 0.05; all results are mean ± SE). Because cardiovascular function after premature birth is improved by the use of antenatal corticosteroids, we also tested the hypothesis that corticosteroid administration would evoke a more pronounced sympathetic response in prematurely delivered lambs (n = 7, 118- to 125-day gestation). After maternal administration of dexamethasone (5 mg im, 48 and 24 h before delivery), RSNA increased after birth in six of seven fetuses to 166 ± 32% of the fetal RSNA value. Dexamethasone treatment also decreased the sensitivity of baroreflex-mediated changes in HR in response to increases in MABP. Because the sympathetic response at birth is depressed in preterm compared with term lambs, we performed an additional study (n = 8) to determine if immature sheep are capable of mounting a sympathetic response to cold. In utero cooling produced rapid and sustained increases in MABP (20 ± 4%), HR (26 ± 6%), and RSNA (282 ± 72%) (all P < 0.05), consistent with a generalized sympathoexcitation. These results suggest that sympathoexcitation is absent after premature delivery despite the presence of functional descending autonomic pathways. Furthermore, exogenous corticosteroids appear to have a maturational effect on the sympathetic response at birth, which may be one mechanism by which maternal steroid administration improves postnatal cardiovascular homeostasis.
renal sympathetic nerve activity; dexamethasone; blood pressure; heart rate; fetus; newborn
| |
INTRODUCTION |
|---|
|
|
|---|
NUMEROUS CARDIOVASCULAR, pulmonary, and metabolic adjustments are required at birth to ensure successful adaptation to the extrauterine environment (20). Previous studies have suggested that activation of the sympathoadrenal system, including a surge in adrenal catecholamine release (12, 19) and stimulation of sympathetic nerve activity (25), participates in regulating these physiological responses. Interestingly, preterm animals and human infants have attenuated physiological adaptive responses at birth compared with those delivered at term, despite having greater increases in circulating catecholamine levels (18, 22). Immaturity of neurohumoral systems, receptor mechanisms, and end-organ function may all contribute to impairment of physiological adaptation at preterm birth.
Before birth, there are programmed increases in circulating levels of several neuroendocrine mediators, including cortisol (17). The increasing availability of endogenous glucocorticoids late in fetal development modulates the rate of differentiation of numerous tissues, the most well studied being the lung (3). The enhancement of fetal lung structural and functional maturity by administration of corticosteroids to pregnant women has been extensively reviewed (2). In addition, studies in premature animals (21, 32) and human infants (10) have documented that antenatal corticosteroid administration improves cardiovascular status at birth and lessens the incidence of as well as the morbidity and mortality related to hemorrhagic and ischemic complications (5). The mechanisms by which antenatal corticosteroids facilitate postnatal circulatory function are uncertain but may be related in part to augmented cardiac and peripheral adrenergic (32) and angiotensinergic (34) functions. Corticosteroids may also influence the development of other neurohumoral systems regulating cardiovascular function at birth, including noradrenergic activity (26).
We have recently shown in term fetal sheep that efferent sympathetic nerve activity increases severalfold at birth and likely contributes to the cardiovascular changes after the transition from fetal to newborn life (25). Absence or attenuation of this sympathoexcitatory response may in turn contribute to the impaired cardiovascular responses at birth in preterm lambs. Therefore, the present studies were designed to investigate the sympathetic response at birth in preterm sheep and to determine if the increase in renal sympathetic nerve activity (RSNA) is impaired compared with that seen in term animals. Furthermore, we examined the effects of antenatal glucocorticoid administration on birth-related changes in systemic hemodynamics and RSNA in preterm fetal lambs. Because the sympathetic response at birth was attenuated in preterm lambs, we performed an additional study to determine if immature sheep are capable of mounting a sympathetic response to other stimuli, namely in utero cooling. We compared our results with those previously published in term fetal sheep.
| |
METHODS |
|---|
|
|
|---|
Studies were performed in conscious, chronically instrumented fetal sheep at 118- to 125-day gestational age (term 145 days). Pregnant ewes of Dorset and Suffolk mixed breeding were obtained from a local source; gestational ages were based on the induced ovulation technique as previously described (9). Ewes were randomized to receive either saline or dexamethasone (Dex, 5 mg im) 48 and 24 h before delivery.
Surgical preparations. All procedures were performed within the regulations of the Animal Welfare Act and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Briefly, the ewe was fasted for 24 h before surgery and anesthetized using a mixture of halothane (1%), oxygen (33%), and nitrous oxide (66%). For the first series of studies, the uterus was opened under sterile conditions over the fetal hindlimbs, and polyethylene catheters were placed into the fetal femoral arteries and veins bilaterally. A catheter for recording amniotic pressure was also secured to the fetal skin. The left kidney, renal artery, and renal nerves were exposed through a flank incision, and a plastic-coated copper wire, used as a ground wire, was secured in the paravertebral muscle. After isolation of a branch of the left renal nerve bundle, platinum electrodes were secured onto the nerve for recording of RSNA as described previously (30). Function of the renal nerve was tested by audible monitoring of pulse-synchronous bursts of neural activity and by examining oscilloscope tracings during bolus phenylephrine infusion. When function was demonstrated, electrodes were secured using Sil-Gel (Sil-Gel 604A and 604B, Wacker-Chemie, Munich, Germany) and the flank incision was closed in separate layers. Fetal skin incisions were closed, and the fetus was returned to the uterus. Maternal incisions were closed in separate layers. All catheters and tubing were exteriorized through subcutaneous tunnels and placed in cloth pouches on the ewe's flank. Ampicillin sodium (Wyeth Laboratories) was administered to the ewe intramuscularly before surgery (2 g) and was infused into the amniotic cavity after surgery (2 g).
In the second group of fetuses, the uterus was opened under sterile conditions over the fetal head, and the head, forelimbs, and thorax were exteriorized. Approximately 5 m of tubing from a closed injectate delivery system (model 93-600, Baxter Healthcare, Irvine, CA) was wrapped around the fetal thorax and secured to the skin. A thermister (Gould test and measurement group, Valley View, OH) was then inserted into the fetal esophagus and secured in place to the corner of the mouth. Fetal skin incisions were closed, and the fetus was returned to the uterus. Femoral arterial and venous catheters as well as a left renal nerve recording electrode were placed as described above. After surgery, pregnant ewes were returned to individual pens and allowed free access to food and water. Twenty-four hours were allowed for recovery from surgery before experiments were performed.Physiological studies.
Before the start of the experiments, the ewe was transferred to the
laboratory in a small cart that was placed in a Faraday cage. The
pregnant ewe was then sedated with diazepam (0.3 mg/kg), given an
intravenous bolus infusion of vecuronium bromide (0.1 mg/kg),
intubated, and ventilated to maintain venous blood gas values similar
to those obtained during spontaneous respiration. Sedation with
diazepam and paralysis has previously been shown to have no effect on
heart rate (HR), arterial pressure, or plasma catecholamine
concentrations in lambs (29). Diazepam (0.1 mg/kg estimated
wt) and vecuronium (0.1 mg/kg estimated wt) were also administered to the fetus. Muscle paralysis was necessary to eliminate movements that interfere with nerve recording. Additional doses of
vecuronium (0.01 mg/kg) were administered when movement was detected.
During the experiments, a constant infusion of a solution of 5%
dextrose and 0.2% sodium chloride was administered to the ewe at a
rate of 125 ml/h and to the fetus at 100 ml · kg
1 · day
1.
After intubation, a 1-h stabilization period was allowed before the
start of the experiment.
Experimental protocol.
The first series of studies (n = 13)
was designed to characterize the changes in systemic hemodynamics,
RSNA, and baroreflex function at birth in preterm lambs and to
determine the effects of prenatal corticosteroid administration on
these autonomic responses. Fetal baseline values for HR, MABP, and RSNA
were obtained by recording and averaging those values over a 30-min
period. Baroreflex function in the fetus was then determined by
producing ramp changes in MABP with a continuous intravenous infusion
of progressive doses of phenylephrine (1-30
µg · kg
1 · min
1)
over a 3- to 5-min period using a Harvard infusion pump, while simultaneously recording HR and RSNA. A 30- to 40-min recovery period
was allowed for MABP, HR, and RSNA to return to baseline values. After
this recovery period, the amount of background noise in the nerve
signal was assessed by inhibiting nerve activity using an intravenous
infusion of the ganglionic blocking agent tetraethylammonium bromide
(10 mg/kg). Integrated RSNA was corrected by subtracting the background
noise level obtained in the presence of ganglionic blockade.
Analytic procedures. Arterial blood for pH, PCO2, and PO2 was collected anaerobically in heparinized syringes, and measurements were immediately determined using a BGM 1302 pH/blood gas analyzer (Instrumentation Laboratory, Lexington, MA). All blood gas values were corrected for fetal temperature. Measurements of cortisol, AVP, ANG II, and catecholamines were performed by radioimmunoassay (University of Iowa Cardiovascular Center RIA Core Facility, Donna B. Farley, Director).
Computation and data analysis. RSNA was normalized for each animal and expressed as the percentage of activity observed in the fetus under control conditions. Statistical analyses of differences in HR, MABP, RSNA, plasma hormone concentrations, and arterial blood gas values during the described study periods were performed using a two-way repeated-measures analysis of variance (ANOVA), factoring for treatment group and time. If the F value for the interactive term (group × time) was found to be significant (P < 0.05), indicating that differences between groups depend upon what level of time (fetus vs. 1 h vs. 4 h) is present, pairwise multiple-comparison procedures were performed by the Student-Newman-Keuls method (7). For data exhibiting a lack of homogeneity of variances among groups, nonparametric analysis was applied using the Kruskal-Wallis test.
For determination of baroreflex control of HR, control values of HR were defined as 100%. HR values were collected at 5-mmHg increments from control MABP (+5, 10, and 15 mmHg) for data analysis. Linear regression analysis of the changes in HR (expressed as %control HR) with increasing MABP was performed, with the differences in the slopes of the regression lines determined by analysis of variance. Differences in changes in HR were also analyzed by three-factor ANOVA (factoring for group, age, and change in blood pressure). Differences were considered significant when P < 0.05. All results are expressed as means ± SE.| |
RESULTS |
|---|
|
|
|---|
Effect of delivery on arterial blood values. Fetal and newborn arterial blood values before and after delivery are summarized in Table 1. Fetal arterial PO2, PCO2, and pH were similar in preterm control and Dex-treated animals. After birth, significant decreases in pH and increases in PO2 were seen in both groups of animals. Arterial pH was significantly higher in Dex animals at 1 and 4 h after birth compared with control animals, whereas no differences in newborn PO2 or PCO2 values were seen between the two groups.
|
Effect of delivery on systemic hemodynamics and RSNA.
The changes in HR, MABP, and RSNA occurring with delivery in term and
preterm sheep are shown in Fig. 1. Data for
the term sheep have previously been published by our group (25) and are presented for comparison with values obtained in preterm sheep. In
contrast to term sheep, in which significant increases in HR and MABP
occur after birth, preterm sheep failed to demonstrate increases in
either HR or MABP after delivery. In fact, by 4 h after birth, HR was
significantly less than that seen in the fetus (
31 ± 6%,
P < 0.05). Large differences in the
sympathetic response at birth were also seen between term and preterm
sheep. One hour after delivery, RSNA increased by almost 250%
(P < 0.05) in term fetuses, and remained at this level at 4 h after birth. However, in
preterm fetuses, RSNA actually decreased after birth,
(P < 0.05 at 1 and 4 h) being
~35-40% of the value obtained in utero.
|
Effect of antenatal Dex on baroreflex control of HR before and after
birth.
Progressive intravenous administration of increasing doses of
phenylephrine resulted in increases in MABP and pressure-related decreases in HR (Fig. 2). Values for HR
after 10- and 15-mmHg increases in MABP were significantly lower in
control animals than in those receiving Dex. Using linear regression
analysis, we found significant differences in the slope of the
relationship between MABP and HR in Dex and control fetuses (
1.8 ± 0.4 vs.
3.5 ± 0.9%/mmHg, respectively). The slope of
the baroreflex response for HR was also significantly greater
(P < 0.05) in control (
4.7 ± 1.0%/mmHg) than in Dex newborns (
1.9 ± 0.3%/mmHg).
Within each treatment group, no differences were detected in the
MABP-HR slope between fetal and newborn values.
|
|
Effects of in utero cooling on arterial blood values. Arterial blood values during control conditions and after fetal cooling, fetal rewarming, and delivery are shown in Table 2. Arterial PCO2 remained unchanged throughout the experiment. Arterial pH was significantly lower after birth compared with all fetal conditions, whereas PO2 was significantly higher after birth. Plasma AVP, ANG II, and cortisol concentrations remained unchanged throughout the study. Norepinephrine levels were increased (P < 0.05) during the fetal cooling and newborn periods, whereas epinephrine levels increased only after birth.
|
Effects of in utero cooling on systemic hemodynamics and RSNA. Ten to fifteen minutes after the beginning of in utero cooling of the fetus, during which time fetal core temperature decreased by ~2°C, significant increases in HR (26 ± 6%), MABP (20 ± 4%), and RSNA (282 ± 72%) were demonstrated (Fig. 4). Notably, significant changes in systemic hemodynamics and RSNA occurred within minutes after cooling began, before any significant decrease in core temperature. Five minutes after the start of the water pump, at a time when fetal core temperature had decreased by 0.4 ± 0.1°C, HR, MABP, and RSNA had increased by 23, 17, and 259%, respectively. Rewarming of the fetus returned HR, MABP, and RSNA to values similar to those observed during the control period. The final intervention of the experiment consisted of delivering the fetus by cesarean section. During this period, HR remained similar to that observed during the fetal control period and after rewarming. However, in contrast to fetuses not previously cooled in utero (first series of studies), animals delivered after cooling and rewarming demonstrated significant increases in MABP (10 ± 2 mmHg) and RSNA (145 ± 62%) by 1 h after birth. This increase in RSNA was also significantly greater than that seen in Dex animals at birth.
|
| |
DISCUSSION |
|---|
|
|
|---|
In previous experiments in term fetal sheep, we demonstrated that sympathetic outflow, as measured in the renal nerve, increases dramatically at birth and parallels the increases in HR and arterial pressure (25). The present studies were designed to characterize the changes in RSNA at birth in preterm fetal lambs and to investigate the effects of antenatal glucocorticoid administration on the sympathetic response and baroreflex control of HR at birth. The results from these studies indicate that in contrast to lambs delivered at term, a sympathoexcitatory response is absent at birth in preterm sheep. However, preterm fetal sheep of ewes receiving antenatal glucocorticoids had improved cardiovascular and sympathetic function at birth compared with control animals of similar gestational age. Glucocorticoids also decreased the sensitivity of the cardiac baroreflex after birth. The impaired sympathetic response at birth seen in non-Dex-treated fetuses occurred despite the fact that the descending pathways of the sympathetic nervous system appear intact and functional at this stage of development, as demonstrated by the large pressor and sympathoexcitatory response to in utero cooling.
Postnatal cardiovascular and metabolic functions are attenuated after premature birth compared with those seen at term (22). These maturational differences cannot be attributed to adrenal unresponsiveness because postnatal circulating catecholamine levels are higher in preterm than term animals (22). Investigators have therefore speculated that immature or incomplete end-organ responses to adrenergic receptor stimulation in target tissues contribute to these impaired responses (21, 32) or that other neurohumoral mechanisms are involved in regulating the physiological adjustments at birth which are not fully developed in the preterm animal. In contrast to our previous observations in term sheep, the present results demonstrate that a sympathoexcitatory response is absent at birth in preterm sheep and that RSNA actually decreases after birth. We speculate that this impaired sympathetic response accompanying premature birth contributes to the attenuated postnatal cardiovascular responses seen with prematurity and suggest that autonomic modulation of circulatory function is of major importance in adaptation to the extrauterine environment.
The effects of corticosteroids on fetal lung development and pulmonary
function are well known (2). More recently, it has been appreciated
that the use of antenatal glucocorticoids improves cardiovascular
function after premature birth (10, 21, 32). Both maternal and direct
fetal administration of glucocorticoids improve postnatal blood
pressure, cardiac output, and cardiac contractility in prematurely
delivered lambs, although the mechanisms regulating these responses are
not clearly understood (21, 31, 32). Stein et al. (32) demonstrated
that myocardial adenylyl cyclase activity is augmented in
corticosteroid-treated fetal lambs, although myocardial
-receptor
density and affinity were similar in treated and nontreated fetuses.
Exogenous cortisol has also been shown in immature fetal sheep to
enhance the vascular responsiveness to ANG II, the levels of which
increase at birth, but not to norepinephrine (6, 34). Finally,
glucocorticoids may also regulate the synthesis of vasoactive
compounds, such as prostaglandins (8) or nitric oxide (33), which in
turn modulate peripheral vascular reactivity.
It may also be hypothesized that the effect of glucocorticoids on postnatal cardiovascular function is mediated by central mechanisms. In the rat brain, glucocorticoid receptors are present in the fetus and increase in number after birth (16). Studies in a number of species have also shown that glucocorticoid receptors are preferentially concentrated within limbic system structures, the paraventricular nucleus of the hypothalamus (PVN), and the nucleus of the solitary tract (16), these latter two regions being strongly implicated as cardiovascular control centers (13). Maternal administration of Dex accelerates development of central noradrenergic function in newborn rats, as measured by norepinephrine turnover (26), and enhances noradrenergic synaptogenesis (27). At a biochemical level, glucocorticoids increase phenylethanolamine N-methyltransferase (PNMT) within the brain stem and hypothalamus of fetal and newborn rats (36). Increased PNMT activity within the central nervous system has been postulated to raise blood pressure by increasing sympathetic activity, although the data are not consistent (11). Interestingly, a number of studies suggest that in adult animals with glucocorticoid hypertension, sympathetic activity appears reduced or unchanged (40, 41). In addition, in adult rats, central administration of Dex exerts a blood pressure-lowering effect, whereas intracerebroventricular injection of a glucocorticoid antagonist increases blood pressure (35, 39). Whether similar effects of central glucocorticoids are present in the developing animal has not been investigated.
The finding that the gain of the HR baroreflex response was reduced in the Dex animals provides additional evidence that glucocorticoids exert an effect on the autonomic nervous system. It is not known whether the effects on the baroreflex were mediated by afferent (within the carotid sinus) or central or efferent (responsiveness of the sinoatrial node) mechanisms. Within the carotid sinus, glucocorticoids may alter the release of endothelial factors that have been shown to contribute to baroreceptor resetting (4). As previously mentioned, glucocorticoid receptors are present in high density within the nucleus of the solitary tract, the initial component of the central baroreflex pathway, as well as the PVN. Alteration of the baroreflex by glucocorticoids may therefore be mediated by effects on neurotransmitters or neuronal activity within these regions. Finally, acute elevations in arterial pressures seen in the Dex-treated fetuses at birth may also contribute to resetting of the baroreflex (4). However, this latter mechanism appears unlikely because 1) the sensitivity of baroreflex responses for HR and RSNA is unchanged immediately after birth in term fetuses despite a significant increase in resting blood pressure (24), and 2) acute (1-2 h) increases in blood pressure produced by phenylephrine do not reset baroreflex function in newborn lambs (24).
Unfortunately, we were not able to reliably assess the RSNA baroreflex. Several animals appeared to have functional baroreflex control of RSNA, whereas in other animals RSNA but not HR appeared dissociated from incremental changes in MABP. These responses are different from those we have previously described in term fetal lambs. In these studies, we found that the sensitivity of the baroreflex-mediated inhibition of RSNA (and HR) was greater in fetal sheep than in 1- and 6-wk-old lambs and parallels the developmental changes observed in the carotid sinus nerve activity. These findings suggest that development of baroreflex control of HR and RSNA are not simultaneous and that in fetal lambs reflex control of HR occurs before control of sympathetic outflow.
We noted that antenatal steroids attenuated the postnatal surge in plasma epinephrine but not in norepinephrine concentrations, whereas other investigators have found both epinephrine and norepinephrine levels to be lower in treated animals (21). Reasons for this difference are unknown but may be related to differences in the type or dosage of glucocorticoid administered or gestational age of the fetuses studied. Catecholamine release from the immature adrenal gland is primarily regulated by nonneurogenic mechanisms that disappear concurrently with the onset of neurogenic control (28). Maturation of neurogenic control may be stimulated by repeated maternal stress during late gestation, neonatal hyperthyroidism (28), and, we speculate, exogenous corticosteroids. Thus the previously observed reduction in plasma epinephrine and norepinephrine levels may result from Dex-induced development of splanchnic nerve function and maturation of neurogenic control of adrenomedullary catecholamine release (28). If indeed neuronal competence is present (or nonneurogenic secretory capabilities are lost) in Dex fetuses, failure of the Dex-treated preterm lamb to generate a large sympathetic response at birth (relative to the term fetus) may therefore result in an impaired postnatal surge in catecholamine release.
Because a sympathoexcitatory response was absent after delivery of preterm lambs, we sought to determine if immature sheep are capable of mounting a sympathetic response to other stimuli. We have previously shown in late-gestation fetal lambs that cooling the fetus in utero by circulating cooled water through tubing wrapped around the fetal thorax produces a >300% increase in RSNA (14). Surprisingly, the immature fetus not treated with Dex displayed a similar pronounced increase in sympathetic outflow, suggesting that at this stage of development, the descending pathways of the sympathetic nervous system are intact and functional. This increase in sympathetic activity was accompanied by increases in HR, blood pressure, and plasma norepinephrine levels. Consistent with that seen in term fetuses, the increase in RSNA was observed with the onset of cooling before a significant decrease in core temperature occurred. In addition, fetal HR, MABP, RSNA, and norepinephrine levels decreased with subsequent rewarming, indicating that the sympathoexcitation was stimulus dependent and likely mediated by sensory input from skin thermal receptors.
The mechanisms regulating sympathoexcitation at birth are not known but
may be related to hypoxemia, acidemia, and surface cooling (14, 38).
The lack of a sympathoexcitatory response at birth in immature animals
suggests that either 1) pathways carrying afferent signals mediating birth-related sympathetic activation are immature, 2) central
integration of these signals is absent, or
3) there is a centrally mediated
suppression of sympathetic outflow. Unexpectedly, we found that preterm
lambs exposed to in utero cooling had augmented cardiovascular and
sympathetic responses at birth compared with noncooled animals at a
similar gestational age. The mechanism(s) for this apparent
facilitative effect of in utero cooling on sympathetic activity at
birth is not known. We speculate that as part of the physiological
response to cooling, modulators of a centrally mediated suppression of sympathetic activity are in turn inhibited or downregulated. Acute cold
stress alters the level and biosynthesis of a number of neuropeptides and neurohormones, including
-aminobutyric acid,
thyrotropin-releasing hormone, corticotropin-releasing hormone, and
neuropeptide Y within the hypothalamus, including the PVN (1, 15, 23,
37, 42). Changes in the expression of these neuromodulators may in turn augment the sympathoexcitatory response at birth.
Perspectives
The mechanisms regulating the numerous physiological adjustments at birth remain largely unknown. This study demonstrates that despite appearing to have intact peripheral adrenergic pathways, preterm sheep have an impaired sympathetic response at birth consistent with the attenuated postnatal changes in cardiovascular function. The maturational effect of glucocorticoids on the sympathetic response at birth may be one mechanism by which maternal steroid administration improves cardiovascular homeostasis after birth and lessens the incidence of complications associated with hypotension and disordered hemodynamic regulation.| |
FOOTNOTES |
|---|
Address for reprint requests: J. L. Segar, Dept. of Pediatrics, Univ. of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242.
Received 30 June 1997; accepted in final form 2 October 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Acosta, G. B.,
M. E. Otero Losada,
and
M. C. Rubio.
Area-dependent changes in GABAeric function after acute and chronic cold stress.
Neurosci. Lett.
154:
175-178,
1993[Medline].
2.
Ballard, P. L.
Hormones and Lung Maturation. Berlin, Germany: Springer-Verlag, 1986, p. 1-345.
3.
Ballard, P. L.,
and
R. A. Ballard.
Scientific basis and therapeutic regimens for use of antenatal glucocorticoids.
Am. J. Obstet. Gynecol.
173:
254-262,
1995[Medline].
4.
Chapleau, M. W.,
G. Hajduczok,
and
F. M. Abboud.
Mechanisms of resetting of arterial baroreceptors: an overview.
Am. J. Med. Sci.
295:
327-334,
1988[Medline].
5.
Crowley, P. A.
Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994.
Am. J. Obstet. Gynecol.
173:
322-335,
1995[Medline].
6.
Davidson, D.
Circulating vasoactive substances and hemodynamic adjustments at birth in lambs.
J. Appl. Physiol.
63:
676-684,
1987
7.
Glantz, S. A.
Primer of Biostatistics. New York: McGraw-Hill, 1992, p. 1-440.
8.
Hyslop, S.,
and
G. De Nucci.
Prostaglandin biosynthesis in the microcirculation: regulation by endothelial and non-endothelial factors.
Prostaglandins Leukot. Essent. Fatty Acids
49:
723-760,
1993[Medline].
9.
Jensen, A.,
O. S. Bamford,
G. S. Dawes,
G. Hofmeyr,
and
M. J. Parkes.
Changes in organ blood flow between high and low voltage electrocortical activity in fetal sheep.
J. Dev. Physiol. (Eynsham)
8:
187-194,
1986[Medline].
10.
Kari, M. A.,
M. Hallman,
M. Eronen,
K. Teramo,
M. Virtanen,
M. Koivisto,
and
R. S. Ikonen.
Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
Pediatrics
93:
730-736,
1994
11.
Kennedy, B.,
H. Elayan,
and
M. G. Ziegler.
Glucocorticoid hypertension and nonadrenal phenylethanolamine N-methyltransferase.
Hypertension
21:
415-419,
1993
12.
Langercrantz, H.,
and
P. Bisoletti.
Catecholamine release in the newborn at birth.
Pediatr. Res.
11:
889-893,
1973[Medline].
13.
Loewy, A. D.
Central autonomic pathways.
In: Central Regulation of Autonomic Functions, edited by A. D. Loewy,
and K. M. Spyer. New York: Oxford University, 1990, p. 88-103.
14.
Mazursky, J. E.,
J. L. Segar,
A.-M. Nuyt,
B. A. Smith,
and
J. E. Robillard.
Regulation of renal sympathetic nerve activity at birth.
Am. J. Physiol.
270 (Regulatory Integrative Comp. Physiol. 39):
R86-R93,
1996
15.
McCarthy, H. D.,
A. P. Kilpatrick,
P. Trayhurn,
and
G. Williams.
Widespread increases in regional hypothalamic neuropeptide Y levels in acute cold-exposed rats.
Neuroscience
54:
127-132,
1993[Medline].
16.
Meyer, J. S.
Biochemical effects of corticosteroids on neural tissues.
Physiol. Rev.
65:
946-1020,
1985
17.
Nathanielsz, P. W.
Adrenocorticotropin.
In: Fetal Endocrinology: An Experimental Approach, edited by P. W. Nathanielsz. Amsterdam, Netherlands: North-Holland, 1976, p. 125-150.
18.
Newnham, J. P.,
C. L. Marshall,
J. F. Padbury,
R. W. Lam,
C. J. Hobel,
and
D. A. Fisher.
Fetal catecholamine release with preterm delivery.
Am. J. Obstet. Gynecol.
149:
888-893,
1984[Medline].
19.
Padbury, J.,
Y. Agata,
J. Ludlow,
M. Ikegami,
B. Baylen,
and
J. Humme.
Effect of fetal adrenalectomy on catecholamine release and physiologic adaptation at birth in sheep.
J. Clin. Invest.
80:
1096-1103,
1987.
20.
Padbury, J. F.,
and
A. M. Martinez.
Sympathoadrenal system activity at birth: integration of postnatal adaptation.
Semin. Perinatol.
12:
163-172,
1988[Medline].
21.
Padbury, J. F.,
D. H. Polk,
G. Ervin,
L. M. Berry,
M. Ikegami,
and
A. H. Jobe.
Postnatal cardiovascular and metabolic responses to a single intramuscular dose of betamethasone in fetal sheep born prematurely by cesarean section.
Pediatr. Res.
38:
709-715,
1995[Medline].
22.
Padbury, J. F.,
D. H. Polk,
J. P. Newnham,
and
R. W. Lam.
Neonatal adaptation: greater sympathoadrenal response in preterm than full-term fetal sheep at birth.
Am. J. Physiol.
248 (Endocrinol. Metab. 11):
E443-E449,
1985
23.
Rage, F.,
J. B. Lazaro,
A. Benyassi,
S. Arancibia,
and
L. Tapia-Arancibia.
Rapid changes in somatostatin and TRH mRNA in whole rat hypothalamus in response to acute cold exposure.
J. Neuroendocrinol.
6:
19-23,
1994[Medline].
24.
Segar, J. L.,
G. Hajduczok,
B. A. Smith,
and
J. E. Robillard.
Ontogeny of baroreflex control of renal sympathetic nerve activity and heart rate.
Am. J. Physiol.
263 (Heart Circ. Physiol. 32):
H1819-H1826,
1992
25.
Segar, J. L.,
J. E. Mazursky,
and
J. E. Robillard.
Changes in ovine renal sympathetic nerve activity and baroreflex function at birth.
Am. J. Physiol.
267 (Heart Circ. Physiol. 36):
H1824-H1832,
1994
26.
Slotkin, T. A.,
S. E. Lappi,
E. C. McCook,
M. I. Tayyeb,
J. P. Eylers,
and
F. J. Seidler.
Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity.
Biol. Neonate
61:
326-336,
1992[Medline].
27.
Slotkin, T. A.,
S. E. Lappi,
M. I. Tayyeb,
and
F. J. Seidler.
Dose-dependent glucocorticoid effects on noradrenergic synaptogenesis in rat brain: ontogeny of [3H]desmethylimipramine binding sites after fetal exposure to dexamethasone.
Res. Commun. Chem. Pathol. Pharmacol.
73:
3-19,
1991[Medline].
28.
Slotkin, T. A.,
and
F. J. Seidler.
Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survival.
J. Dev. Physiol. (Eynsham)
10:
1-16,
1988[Medline].
29.
Smith, F.,
J. Klunkefus,
and
J. Robillard.
Effects on volume expansion on renal sympathetic nerve activity and cardiovascular and renal function in lambs.
Am. J. Physiol.
262 (Regulatory Integrative Comp. Physiol. 31):
R2651-R2658,
1992.
30.
Smith, F. G.,
J. M. Klinefus,
U. C. Koop,
and
J. E. Robillard.
Novel recordings of renal sympathetic nerve activity in conscious fetal sheep and newborn lambs.
Am. J. Physiol.
258 (Renal Fluid Electrolyte Physiol. 27):
F218-F221,
1990
31.
Stein, H. M.,
A. Martinez,
L. Blount,
K. Oyama,
and
J. F. Padbury.
The effects of corticosteroids and thyrotropin-releasing hormone on newborn adaptation and sympathoadrenal mechanisms in preterm sheep.
Am. J. Obstet. Gynecol.
171:
17-24,
1994[Medline].
32.
Stein, H. M.,
K. Oyama,
A. Martinez,
B. A. Chappell,
E. Buhl,
L. Blount,
and
J. F. Padbury.
Effects of corticosteroids in preterm sheep on adaptation and sympathoadrenal mechanisms at birth.
Am. J. Physiol.
264 (Endocrinol. Metab. 27):
E763-E769,
1993
33.
Szabo, C.,
C. Thiemermann,
C. C. Wu,
M. Perretti,
and
J. R. Vane.
Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo.
Proc. Natl. Acad. Sci. USA
91:
271-275,
1994
34.
Tangalakis, T.,
E. R. Lumbers,
K. M. Moritz,
M. K. Towstoless,
and
E. M. Wintour.
Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus.
Exp. Physiol.
77:
709-717,
1992[Abstract].
35.
Tonolo, G.,
P. Soro,
P. Madeddu,
C. Troffa,
M. G. Melis,
G. Patteri,
P. P. Parpaglia,
G. Sabino,
M. Maioli,
and
N. Glorioso.
Effect of chronic intracerebroventricular dexamethasone on blood pressure in normotensive rats.
Am. J. Physiol.
264 (Endocrinol. Metab. 27):
E843-E847,
1993
36.
Turner, B. B.,
R. J. Katz,
and
B. J. Carroll.
Neonatal corticosteroid permanently alters brain activity of epinephrine-synthesizing in stressed cats.
Brain Res.
166:
426-430,
1979[Medline].
37.
Uribe, R. M.,
J. L. Redondo,
J. L. Charli,
and
P. Joseph-Bravo.
Suckling and cold stress rapidly and transiently increase TRH mRNA in the paraventricular nucleus.
Neuroendocrinology
58:
140-145,
1993[Medline].
38.
Van Bel, F.,
C. Roman,
H. S. Iwamoto,
and
A. M. Rudolph.
Sympathoadrenal, metabolic, and regional blood flow responses to cold in fetal sheep.
Pediatr. Res.
34:
47-50,
1993[Medline].
39.
Van den Berg, D. T. W. M.,
E. R. de Kloet,
H. H. Van Dijken,
and
W. de Jong.
Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
Endocrinology
126:
118-124,
1990[Abstract].
40.
Waeber, B.,
H. Gavras,
M. R. Bresnahan,
I. Gavras,
and
H. R. Brunner.
Role of vasoconstrictor systems in experimental glucocorticoid-hypertension in rats.
Clin. Sci. (Lond.)
65:
255-261,
1983[Medline].
41.
Walker, H. C.,
and
D. R. Romsos.
Glucocorticoids in the CNS regulate BAT metabolism and plasma insulin in ob/ob mice.
Am. J. Physiol.
262 (Endocrinol. Metab. 25):
E110-E117,
1992
42.
Yi, S. J.,
and
T. Z. Baram.
Corticotropin-releasing hormone mediates the response to cold stress in the neonatal rat without compensatory enhancement of the peptide's gene expression.
Endocrinology
135:
2364-2368,
1994[Abstract].
This article has been cited by other articles:
![]() |
A. J. Turner, R. D. Brown, M. Carlstrom, K. J. Gibson, and A. E. G. Persson Mechanisms of neonatal increase in glomerular filtration rate Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R916 - R921. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Bal, W. B. de Vries, M. F. M. van Oosterhout, J. Baan, E. E. van der Wall, F. van Bel, and P. Steendijk Long-term cardiovascular effects of neonatal dexamethasone treatment: hemodynamic follow-up by left ventricular pressure-volume loops in rats J Appl Physiol, February 1, 2008; 104(2): 446 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer, A. G. Bechtold, and K. A. Vernon Chronic Activation of Dorsal Hindbrain Corticosteroid Receptors Augments the Arterial Pressure Response to Acute Stress Hypertension, January 1, 2007; 49(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bechtold and D. A. Scheuer Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1003 - R1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer, A. G. Bechtold, S. S. Shank, and S. F. Akana Glucocorticoids act in the dorsal hindbrain to increase arterial pressure Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H458 - H467. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Lumbers, Z.-Y. Yu, and E. N. Crawford Effects of fetal behavioral states on renal sympathetic nerve activity and arterial pressure of unanesthetized fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R908 - R916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Segar, T. Van Natta, and O. J. Smith Effects of fetal ovine adrenalectomy on sympathetic and baroreflex responses at birth Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R460 - R467. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer and A. G. Bechtold Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R475 - R483. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer and A. G. Bechtold Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1719 - R1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer and S. W. Mifflin Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1440 - R1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Segar, K. A. Bedell, and O. J. Smith Glucocorticoid modulation of cardiovascular and autonomic function in preterm lambs: role of ANG II Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R646 - R654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Segar, O. J. Smith, and A. T. Holley Mechano- and chemoreceptor modulation of renal sympathetic nerve activity at birth in fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1295 - R1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wada, M. G. Ervin, and M. Ikegami Effect of ventilation style on cardiovascular and renal adaptation in preterm newborn lambs Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R836 - R843. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||